These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35447464)

  • 1. Release of metal elements from the Essure implant: A prospective cohort study.
    Parant F; Bost M; Nohuz E; Prost J; Cerruto E; Moret S; Maurin J; Chene G
    Eur J Obstet Gynecol Reprod Biol; 2022 Jun; 273():20-25. PubMed ID: 35447464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential release of toxic metal elements from Essure® device in symptomatic patients: First results of the French Ablimco cohort.
    Parant F; Bost M; Nohuz E; Prost J; Cerruto E; Moret S; Maurin J; Chene G
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():434-438. PubMed ID: 32731056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrieval analysis of the Essure® micro insert female sterilization implant: Methods for metal ion and microscopic analysis.
    Goodwin C; Aslan C; Gilbert JL
    Acta Biomater; 2023 May; 162():312-323. PubMed ID: 36963594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure
    Trecourt A; Devouassoux-Shisheboran M; Nohuz E; Cerruto E; Moret S; Hallez D; Miguet-Bensouda C; Chene G
    Eur J Contracept Reprod Health Care; 2023 Aug; 28(4):227-233. PubMed ID: 37365993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of the systematic presence of tin particles in fallopian tubes or uterine horns of Essure implant explanted patients: A study of 18 cases with the same pathological process.
    Catinon M; Roux E; Auroux A; Trunfio-Sfarghiu AM; Lauro-Colleaux C; Watkin E; Sournies G; Vincent M
    J Trace Elem Med Biol; 2022 Jan; 69():126891. PubMed ID: 34749033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of inorganic particles resulting from degradation of ESSURE® implants: Study of 10 cases.
    Catinon M; Roux E; Auroux A; Balter V; Fellah C; Trunfio-Sfarghiu AM; Sournies G; Vincent M
    Eur J Obstet Gynecol Reprod Biol; 2020 Jul; 250():162-170. PubMed ID: 32446147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essure removal: comparison of two minimally invasive approaches.
    Gracia M; Herráez A; Coronado P
    Fertil Steril; 2020 Jul; 114(1):187-188. PubMed ID: 32622410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative findings and complications in Essure® removal surgery.
    Horsten DL; van Gastel DM; Maassen LW; Koks CAM; Veersema S; Bongers MY
    Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():1-6. PubMed ID: 34129961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and peritoneal fluid cytokine profiles in patient with Essure® implant: Towards a molecular signature?
    Garnier L; Parant F; Bulteau C; Pescarmona R; Cerruto E; Moret S; Miguet-Bensouda C; Nohuz E; Chene G
    Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():349-353. PubMed ID: 38537321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey.
    Franchini M; Zizolfi B; Coppola C; Bergamini V; Bonin C; Borsellino G; Busato E; Calabrese S; Calzolari S; Fantin GP; Giarrè G; Litta P; Luerti M; Mangino FP; Marchino GL; Molinari MA; Scatena E; Scrimin F; Telloli P; Di Spiezio Sardo A
    J Minim Invasive Gynecol; 2017; 24(4):640-645. PubMed ID: 28232037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical techniques for the removal of Essure
    Chene G; Cerruto E; Merviel P; Agostini A; Crochet P; Giraudet G; Capmas P; Fernandez H; Graesslin O
    Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):404-412. PubMed ID: 34096440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic Essure® Device Removal by En Bloc Salpingectomy-Cornuectomy with Intraoperative X-Ray Checking: A Retrospective Cohort Study.
    Miquel L; Crochet P; Francini S; Compan C; Boubli L; Agostini A
    J Minim Invasive Gynecol; 2020; 27(3):697-703. PubMed ID: 31212073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of non-gynecological symptoms before and after removal of the Essure® sterilization device: a 6-month follow-up study.
    Merviel P; Kurtz D; Lelievre C; Le Gourrierec A; Postec-Ollitrault E; Dupré PF
    Minerva Ginecol; 2019 Dec; 71(6):404-411. PubMed ID: 32064824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Adverse Events Attributed to Essure Associated With Nickel Sensitization?
    Raison-Peyron N; Du-Thanh A; Compan C; Perrochia H; Francini S; Duflos C; Crochet P
    Dermatitis; 2020; 31(2):122-127. PubMed ID: 32168143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective cost analysis comparing Essure hysteroscopic sterilization and laparoscopic bilateral tubal coagulation.
    Hopkins MR; Creedon DJ; Wagie AE; Williams AR; Famuyide AO
    J Minim Invasive Gynecol; 2007; 14(1):97-102. PubMed ID: 17218238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic Cornuectomy as a Technique for Removal of Essure Microinserts.
    Thiel L; Rattray D; Thiel J
    J Minim Invasive Gynecol; 2017 Jan; 24(1):10. PubMed ID: 27422719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical improvement after Essure® devices removal: a systematic review.
    Miguet-Bensouda C; Parant F; Grenet G; Cerruto E; Nohuz E; Chene G
    Eur J Contracept Reprod Health Care; 2023 Aug; 28(4):238-248. PubMed ID: 37466355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICSI pregnancy outcomes following hysteroscopic placement of Essure devices for hydrosalpinx in laparoscopic contraindicated patients.
    Ozgur K; Bulut H; Berkkanoglu M; Coetzee K; Kaya G
    Reprod Biomed Online; 2014 Jul; 29(1):113-8. PubMed ID: 24813749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical removal of essure® micro inserts by vaginal hysterectomy or laparoscopic salpingectomy with cornuectomy: Case series and follow up survey about device-attributed symptoms resolution.
    Jegaden M; Pourcelot AG; Fernandez H; Capmas P
    J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101781. PubMed ID: 32492524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could the anatomic location of Essure® device explain the impairment of quality of life?
    Chene G; Cerruto E; Moret S; Nohuz E
    Minerva Obstet Gynecol; 2022 Apr; 74(2):123-129. PubMed ID: 35421915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.